The purpose of this study is evaluate patients with acute myeloid leukemia (\<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.
Study Type
OBSERVATIONAL
Enrollment
300
Città della Salute e della Scienza di Torino
Torino, Italy
Overall survival
Time frame: 1 year
Event-free survival
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.